ADNP | Activity-dependent neuroprotector homeobox | Cancer-related genes Transcription factors
| | | | | Expressed in all |
AHR | Aryl hydrocarbon receptor | Cancer-related genes Transcription factors
| | | | | Expressed in all |
ALX1 | ALX homeobox 1 | Disease related genes Transcription factors
| | | | | Tissue enhanced |
AR | Androgen receptor | Cancer-related genes Disease related genes FDA approved drug targets Nuclear receptors Plasma proteins Transcription factors
| | | | | Tissue enhanced |
ARID1A | AT rich interactive domain 1A (SWI-like) | Cancer-related genes Disease related genes Transcription factors
| | | | | Expressed in all |
ARID3B | AT rich interactive domain 3B (BRIGHT-like) | Transcription factors
| | | | | Mixed |
ARNT | Aryl hydrocarbon receptor nuclear translocator | Cancer-related genes Transcription factors
| | | | | Expressed in all |
ARNTL | Aryl hydrocarbon receptor nuclear translocator-like | Predicted secreted proteins Transcription factors
| | | | | Expressed in all |
ATF1 | Activating transcription factor 1 | Cancer-related genes Disease related genes Transcription factors
| | | | | Expressed in all |
ATF2 | Activating transcription factor 2 | Enzymes Transcription factors
| | | | | Expressed in all |
ATRX | Alpha thalassemia/mental retardation syndrome X-linked | Cancer-related genes Disease related genes Enzymes Potential drug targets Transcription factors
| | | | | Expressed in all |
BARX2 | BARX homeobox 2 | Transcription factors
| | | | | Tissue enhanced |
BBX | Bobby sox homolog (Drosophila) | Transcription factors
| | | | | Expressed in all |
BCL6 | B-cell CLL/lymphoma 6 | Cancer-related genes Disease related genes Transcription factors
| | | | | Expressed in all |
BHLHA15 | Basic helix-loop-helix family, member a15 | Transcription factors
| | | | | Group enriched |
BHLHE22 | Basic helix-loop-helix family, member e22 | Transcription factors
| | | | | Tissue enhanced |
CDC5L | Cell division cycle 5-like | Disease related genes Plasma proteins Transcription factors
| | | | | Expressed in all |
CDX1 | Caudal type homeobox 1 | Transcription factors
| | | | | Group enriched |
CDX2 | Caudal type homeobox 2 | Cancer-related genes Transcription factors
| | | | | Group enriched |
CEBPB | CCAAT/enhancer binding protein (C/EBP), beta | Transcription factors
| | | | | Expressed in all |
CEBPE | CCAAT/enhancer binding protein (C/EBP), epsilon | Transcription factors
| | | | | Tissue enriched |
CEBPG | CCAAT/enhancer binding protein (C/EBP), gamma | Transcription factors
| | | | | Expressed in all |
CIC | Capicua transcriptional repressor | Cancer-related genes Transcription factors
| | | | | Expressed in all |
CLOCK | Clock circadian regulator | Enzymes Transcription factors
| | | | | Expressed in all |
CNOT4 | CCR4-NOT transcription complex, subunit 4 | Transcription factors
| | | | | Expressed in all |
CREB1 | CAMP responsive element binding protein 1 | Cancer-related genes Disease related genes Transcription factors
| | | | | Expressed in all |
CREB3L1 | CAMP responsive element binding protein 3-like 1 | Cancer-related genes Predicted membrane proteins Transcription factors
| | | | | Mixed |
CREM | CAMP responsive element modulator | Transcription factors
| | | | | Expressed in all |
CTCF | CCCTC-binding factor (zinc finger protein) | Cancer-related genes Disease related genes Transcription factors
| | | | | Expressed in all |
CTCFL | CCCTC-binding factor (zinc finger protein)-like | Predicted membrane proteins Transcription factors
| | | | | Tissue enriched |
CXXC1 | CXXC finger protein 1 | Transcription factors
| | | | | Expressed in all |
DEAF1 | DEAF1 transcription factor | Predicted secreted proteins Transcription factors
| | | | | Expressed in all |
DMRT1 | Doublesex and mab-3 related transcription factor 1 | Disease related genes Transcription factors
| | | | | Tissue enriched |
DMRTB1 | DMRT-like family B with proline-rich C-terminal, 1 | Transcription factors
| | | | | Tissue enriched |
DMTF1 | Cyclin D binding myb-like transcription factor 1 | Transcription factors
| | | | | Expressed in all |
DNMT1 | DNA (cytosine-5-)-methyltransferase 1 | Disease related genes Enzymes FDA approved drug targets Plasma proteins Transcription factors
| | | | | Expressed in all |
DNMT3A | DNA (cytosine-5-)-methyltransferase 3 alpha | Cancer-related genes Enzymes Plasma proteins Transcription factors
| | | | | Expressed in all |
E2F1 | E2F transcription factor 1 | Cancer-related genes Plasma proteins Transcription factors
| | | | | Tissue enhanced |
EGR1 | Early growth response 1 | Cancer-related genes Plasma proteins Transcription factors
| | | | | Expressed in all |
EGR3 | Early growth response 3 | Transcription factors
| | | | | Mixed |
ELF2 | E74-like factor 2 (ets domain transcription factor) | Transcription factors
| | | | | Expressed in all |
ELF3 | E74-like factor 3 (ets domain transcription factor, epithelial-specific ) | Cancer-related genes Transcription factors
| | | | | Mixed |
ELK1 | ELK1, member of ETS oncogene family | RAS pathway related proteins Transcription factors
| | | | | Expressed in all |
ELK4 | ELK4, ETS-domain protein (SRF accessory protein 1) | Cancer-related genes Transcription factors
| | | | | Expressed in all |
ESR1 | Estrogen receptor 1 | Cancer-related genes Disease related genes FDA approved drug targets Nuclear receptors Transcription factors
| | | | | Tissue enhanced |
ESX1 | ESX homeobox 1 | Transcription factors
| | | | | Tissue enriched |
ETV3 | Ets variant 3 | Plasma proteins Transcription factors
| | | | | Expressed in all |
ETV4 | Ets variant 4 | Cancer-related genes Transcription factors
| | | | | Mixed |
ETV5 | Ets variant 5 | Cancer-related genes Transcription factors
| | | | | Mixed |
FOSL2 | FOS-like antigen 2 | Transcription factors
| | | | | Expressed in all |